Phospholipids profiling and outcome of peritoneal dialysis patients.
Wen Tang, Min Li, Xin-Hong Lu, Hu-Wei Liu, Tao Wang
文献索引:Biomarkers 19(6) , 505-8, (2014)
全文:HTML全文
摘要
To investigate phospholipids (PLs) biomarkers in predicting outcome of patients undergoing peritoneal dialysis (PD).Twenty PD patients were followed using baseline plasma PLs with an improved online two-dimensional liquid chromatography-quadrupole time-of-flight mass spectrometry system.Significant differences were observed in eight PL species with sphingomyelin (SM) and glycerophosphocholine between technical survival (n=15) and failure patients (n = 5). Cox regression showed SM 21:0 (adjusted HR 13.7, 95% CI 2.42-77.88, p = 0.003) was independently associated with patients technical failure.PD failure patients had different plasma PLs profiling as compared with survival patients. Elevated plasma SM 21:0 level may potentially serve as a biomarker of PD patients at risk for adverse outcomes.
相关化合物
相关文献:
2015-01-01
[Arch. Toxicol. 89(1) , 107-19, (2015)]
2014-09-01
[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 966 , 193-9, (2014)]
2014-04-15
[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 957 , 30-5, (2014)]
2014-01-01
[Mol. Cancer 13 , 259, (2014)]
2015-02-13
[J. Chromatogr. A. 1381 , 140-8, (2015)]